000			04922nam a22003855i 4500
001			394069
003			ES-MaUEC
005			20230102123050.0
007			cr nn 008mamaa
008			220928s2022 sz | s |||| 0|eng d
020			_a9783031109928
024	7		_a10.1007/978-3-031-10992-8 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC
245	1	0	_aAntibiofilm Strategies _bCurrent and Future Applications to Prevent, Control and Eradicate Biofilms _cedited by Katharina Richter, Kasper Nørskov Kragh
250			_a1st edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XV, 573 páginas) _b49 ilustraciones, 46 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aSpringer Series on Biofilms _x1863-9615 _v11
505	0		_aPart 1: Introduction -- Chapter 1: Preface: Biofilms 101 -- Chapter 2: Antimicrobial and innate immune tolerance mechanisms in biofilms -- Chapter 3: Antibiotic resistance development in bacterial biofilms -- Part 2: Biofilm Prevention & Treatment -- Chapter 4: Prevention of biofilms in catheter-associated urinary tract infections -- Chapter 5: Probiotics' action against biofilms -- Chapter 6: Clinical translation of biofilm dispersal agents -- Chapter 7: Chemical regulation of Pseudomonas aeruginosa biofilm formation as a potential treatment for persistent infections -- Chapter 8: Bacteriophages for the treatment of biofilm-associated infections -- Chapter 9: Hyperbaric oxygen treatment may advance the outcome of antibiotic treatment of biofilm infections -- Chapter 10: Cold plasma therapy as a physical antibiofilm approach -- Chapter 11: Antibodies against biofilms: Mechanisms and applications -- Chapter 12: Host defense peptides: Multifront attack on biofilms -- Chapter 13: Learning from nature: Naturally derived remedies -- Chapter 14: Historical medical remedies as potential anti-biofilm approaches: Can we look back to move forward? -- Part 3: Biofilm Control -- Chapter 15: The action of phytochemicals in the control of pathogenic biofilms -- Chapter 16: Current and future applications to control polymicrobial biofilms associated with oral disease -- Chapter 17: Clinical management of fungal biofilm infections -- Chapter 18: Metal-based nanoparticles for biofilm treatment and infection control: From basic research to clinical translation -- Chapter 19: Nitric oxide-mediated dispersal as an adjunctive strategy for the control of biofilm-associated infection -- Chapter 20: Biofouling control in water filtration systems -- Chapter 21: Biofilm in equine and other veterinary wounds.
520			_aBacteria and fungi are able to aggregate together or on surfaces in densely packed microcolonies, facilitated by extracellular polymeric substances for cell protection and stability. These biofilms have proven to be extremely hard to eradicate and remove once established. In chronic infections, this condition can result in a high degree of morbidity and mortality as regular antibiotic treatments are ineffective against biofilms. In industrial facilities, the formation of biofilms can ruin production and result in enormous financial losses. In this book, the current state of antibiofilm research is presented by experts from around the world. Novel, cutting-edge techniques and new optimized strategies based on established methods are discussed in chapters focused on biofilm prevention, treatment and control for the application in clinical, industrial and veterinary settings. Antibiofilm strategies, such as chemical and enzymatic treatments, surface modification and coatings, quorum sensing inhibition and dispersal induction, phage therapy, cold plasma treatment, hyperbaric oxygen treatment, and metal-based nanomedicine are covered, among many others. This book contributes to the UN's Sustainable Development Goal 3: Good Health and Well-Being and is a valuable resource for healthcare professionals, microbiologists, academics and for educators to inform curricula of universities and colleges.
700	1		_aRichter, Katharina _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aKragh, Kasper Nørskov _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783031109911
776	0	8	_iPrinted edition: _z9783031109935
776	0	8	_iPrinted edition: _z9783031109942
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-10992-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
988			_aSpringer_BiomedLife_2022
999			_c394069 _d394069